We offer custom CRISPR/Cas9-mediated knockout cell line generation to meet your specific gene targeting needs. Using advanced gene-editing platforms, we disrupt target genes in a range of mammalian cell lines, followed by clonal selection and comprehensive validation (including DNA sequencing and protein expression analysis). Our streamlined process delivers high-quality, isogenic knockout cell lines efficiently, enabling robust studies of gene function, drug response, and disease mechanisms.